SERA Stock Price
Sera Prognostics, Inc.
SERA stock price is $2.07 (+1.47% on the day), giving Sera Prognostics, Inc. a market cap of $81.66M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
SERA Stock Overview
- Price
- $2.07
- Previous close
- $2.04
- Open
- $2.03
- Market cap
- $81.66M
- P/E ratio
- -2.6
- 52-week range
- $1.56 - $3.95
- 1-year price target
- $5.50
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NSD
- MarketXLS Rank
- 56
About Sera Prognostics, Inc.
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SERA | $2.07 | +1.5% | 5.84K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |